- £198.21bn
- £217.54bn
- $54.07bn
- 85
- 16
- 86
- 71
REG - AstraZeneca PLC - AstraZeneca divestment of Movantik completed
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Imfinzi approved in US for small cell lung cancer
AnnouncementREG - AstraZeneca PLC - Farxiga CKD trial early stop for positive efficacy
AnnouncementREG - AstraZeneca PLC - Lokelma approved in Japan for hyperkalaemia
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Second Price Monitoring Extn
AnnouncementREG - AstraZeneca PLC - Price Monitoring Extension
AnnouncementREG - AstraZeneca PLC - Price Monitoring Extension
AnnouncementREG - AstraZeneca PLC - Second Price Monitoring Extn
AnnouncementREG - AstraZeneca PLC - Price Monitoring Extension
AnnouncementREG - AstraZeneca PLC - Second Price Monitoring Extn
AnnouncementREG - AstraZeneca PLC - Price Monitoring Extension
AnnouncementREG - AstraZeneca PLC - Second Price Monitoring Extn
AnnouncementREG - AstraZeneca PLC - Price Monitoring Extension
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - Lynparza granted orphan drug designation in Japan
AnnouncementREG - AstraZeneca PLC - Imfinzi confirmed overall survival in CASPIAN
Announcement